Samsung’s $67.5M Patent Infringement Award Nullified Due to Juror Confusion

In a recent development involving tech giant Samsung Electronics Co., a $67.5 million patent infringement award that was to be given to G+ Communications LLC has been nullified. This substantial award was earlier decreed over the alleged usage of unlicensed technology in Samsung’s Galaxy 5G smartphones. Interestingly, the January verdict wasn’t able to hold water…

Read More

Paul Hastings Bolsters Tech Presence with Six-Partner IP Litigation Team from Allen & Overy

In a significant move for the legal industry, Paul Hastings has hired a six-partner intellectual property (IP) litigation team from Allen & Overy. Expanding its tech-focused offerings in Northern California, the team will be based in Palo Alto, New York, and Washington, D.C. A major component of this team’s expertise lies in patent litigation and…

Read More

Paul Hastings Boosts IP Litigation Practice with Six-Partner Team from Allen & Overy

In a notable development, law firm Paul Hastings has recruited a technology-focused intellectual property (IP) litigation team consisting of six partners from Allen & Overy. This hiring complements a series of group hires instigated earlier this year by Paul Hastings. The newly engaged partners, who will operate out of Palo Alto and Washington, DC, while…

Read More

Sarah Mirza Joins Squire Patton Boggs as Intellectual Property Partner in Palo Alto

Renowned law firm Squire Patton Boggs recently welcomed intellectual property (IP) legal expert Sarah Mirza to their team as a partnering member. Mirza’s addition to the intellectual property and technology department was announced on a company press report issued last Thursday. Mirza is an established name in Silicon Valley. She specializes in building robust patent…

Read More

Patent Lawyer Liability Debates in Federal Circuit Amid Fee-Shifting Appeal

The Federal Circuit, the nation’s highest patent court, is currently wrestling with an appeal that could significantly alter the landscape for attorneys involved in patent infringement lawsuits. The impact on patent professionals and practitioners in major corporations and law firms, which represent some of the world’s most prolific filers of such lawsuits, could be significant….

Read More

Spencer Fane Expands IP Practice with Trio of Ex-McKool Smith Professionals

Spencer Fane LLP recently fortified its growing intellectual property (IP) division with the acquisition of three adept attorneys from McKool Smith. The trio, known for their specialization in patent and trade secrets disputes, have built reputations as experts in high-stakes, ‘bet-the-company’ litigation. This news comes as Spencer Fane is engaged in a period of expansion,…

Read More

KPN’s $287 Million Patent Dispute Verdict Against Samsung Faces Federal Scrutiny

In a recent legal development, a jury verdict of $287 million, secured by law firm Susman Godfrey, is being scrutinized in a federal court. The case concerns Netherlands-based company Koninklijke KPN N.V. and involves a breach-of-settlement agreement pertinent to patent infringement lawsuits. KPN brought forward that Samsung Electronics America Inc., the defendant, inadequately moved this…

Read More

Ramey LLP Escapes Bad Faith Allegations in Vizio Patent Infringement Lawsuit

In a recent legal skirmish, Texas-based law firm Ramey LLP successfully thwarted allegations accusing it of improper conduct while prosecuting a patent infringement lawsuit against Vizio Inc. The lawsuit pertained to methods for brokering data. Contrary to Vizio’s allegations, Ramey did not act in bad faith when representing Ortiz & Associates Consulting LLC in a…

Read More

NRA Leaders Breach Duties, Face No Financial Consequences: Implications for the Organization

In a trial revealing internal tensions within the National Rifle Association (NRA), the organization’s general counsel and two other senior leaders were found by jurors to have violated their statutory duties. However, it was concluded that these transgressions did not result in any financial loss for the NRA. The trial shed light on controversies within…

Read More

USPTO Outlines Obviousness Guidelines: Implications for Utility and Design Patent Prosecutors

On Tuesday, the U.S. Patent and Trademark Office released new guidance to determine “obviousness” in patents, stemming from recent Supreme Court precedent. Intellectual Property (IP) attorneys have stated that although the new guidelines could simplify procedures for utility patent prosecutors and their clients, there remain open questions about the application of this precedent on design…

Read More

Lab-Grown Diamond Patent Litigation: A Cautionary Tale on Investment and Legal Risks

Patent cases can often linger unresolved, particularly when the defendant is able to demonstrate the case lacked the necessary foundation to be brought forward in the first place. Until there exist mechanisms for certain patent claims to be expediently disposed of using alternative dispute mechanisms, such cases are likely to persist. It’s thus crucial, in…

Read More

Sheppard Mullin Bolsters San Diego IP Practice with Life Sciences Expert Jaime Choi

Sheppard Mullin has announced an expansion to its intellectual property practice in San Diego with the addition of a new partner, Jaime Choi. Highly skilled in patent prosecution, Choi has expertise in creating global IP portfolios, preparing opinions, and conducting product clearance for clients in the life sciences and high technology sectors. This information was…

Read More

Shift in PTAB Decisions Impacting Medical AI Patent Approvals and Appeals

Medical technology incorporating artificial intelligence (AI) is increasingly coming under scrutiny by Patent Trial and Appeal Board (PTAB). Recent decisions from the board have shown a trend of reversal on prior art rejection. This offers a contrasting view to the previous decisions with regards to the subject matter eligibility. Innovations under consideration encompass a variety…

Read More

Dismantling Pharma Patent Thickets: New Legislation to Curb Drug Costs and Spur Innovation

In an effort to tackle patent thickets and reduce the cost of pharmaceutical drugs, US Senators Peter Welch (D-VT) and Amy Klobuchar (D-MN) recently hosted a bipartisan panel discussion to present a new legislation. The panel, entitled ‘Breaking Down Big Pharma Patent Walls’, was held at the Russell Senate Office Building on Capitol Hill. Understanding…

Read More

Lawsuit Challenges South Carolina Prison Policy, Alleges First Amendment Violations

The American Civil Liberties Union (ACLU) and ACLU of South Carolina have brought to light a contentious issue with a lawsuit against the South Carolina Department of Corrections (SCDC). The central argument is that the department’s policy, which prevents inmates from having personal contact interviews, including with news media, stands in violation of the First…

Read More

Third Circuit Denies AbbVie’s Plea Over Atty-Client Communications in Patent Dispute

In a recent development, the Third Circuit has declined AbbVie Inc.’s plea to prevent a Pennsylvania federal court’s command to disclose attorney correspondences from a contentious patent case. The case has been accused of being deliberately instigated to safeguard AbbVie’s exclusive rights on a testosterone drug. The court has yet to release a detailed explanation…

Read More